Latest Conference Coverage
Perspectives From a Neurology Career in Industry and Academia: Jean Hubble, MD
June 19th 2022Despite a less than favorable view of the pharmaceutical industry among the general population, there are still benefits to the work being done by clinicians who transition to this line of work according to the semi-retired neurologist and consultant with the PMD Alliance. [WATCH TIME: 2 minutes]
Physician Estimates of Needle Phobia Might Be Overstated Among Patients With Parkinson Disease
June 18th 2022A survey of more than 4000 individuals with PD and their caregivers suggests that almost 90% would be willing to use subcutaneous injectable therapies to control their disease, contrasting the current anecdotal belief of “needle phobia” in this population.
The Interdisciplinary Care Team in Movement Disorder Care: Jean Hubble, MD
June 18th 2022The semi-retired neurologist and consultant with the PMD Alliance discussed the importance of the patient care team and having multiple specialists and disciplines included in that process. [WATCH TIME: 2 minutes]
The Importance of Treatment Nuance and Novel Options in Treating Parkinson Disease
June 18th 2022In a presentation at the 2022 ATMRD Congress, Jill Farmer, DO, MPH, outlined several novel options for the treatment of OFF episodes in Parkinson disease, and stressed the need for individualized approaches to maximize patient quality of life.
Social Prescribing and Advances in Therapy for Movement Disorders: Jean Hubble, MD
June 17th 2022The semi-retired neurologist and consultant with the PMD Alliance shared her perspective on the progress that has been made in therapeutics for the treatment of movement disorders, and the role of social prescribing for these patients. [WATCH TIME: 3 minutes]
Understanding Treatment Decisions and Differences Between Diroximel Fumarate and Dimethyl Fumarate
June 16th 2022Meghan Garabedian, CRNP, MSN, nurse practitioner at the Penn Neuroscience Center, discussed her presentation at the 2022 CMSC Annual Meeting regarding the patient experience on diroximel fumarate.
Improving the Understanding of Narcolepsy and its Pathophysiology: Richard Bogan, MD, FCCP, FAASM
June 16th 2022The associate clinical professor at the University of South Carolina School of Medicine discussed the strides, but also challenges still in treating patients with narcolepsy. [WATCH TIME: 2 minutes]
The Importance of Sleep Quality for Cognitive Health Throughout the Stages of Menopause
June 15th 2022Galit L. Dunietz, PhD, MPH, assistant professor of neurology, University of Michigan, provided insight on women’s health, menopause cycles, and how sleep can have a direct impact on long-term cognitive health.
The Effect of Mindfulness Practices on Migraine: Paige Estave, PhD
June 15th 2022The MD-PhD student at Wake Forest School of Medicine shared her perspective on the findings of a study suggesting that mindfulness practices can alter pain perception and migraine attack awareness, among other results. [WATCH TIME: 4 minutes]
Children, Adolescents With Migraine Show High Risk for Anxiety and Depression Symptoms
June 14th 2022A systematic review and meta-analysis suggested that the risk of anxiety and depressive symptoms was nearly doubled for those with migraine compared with healthy controls, indicating a need to screen this patient population.
The Endocannabinoid System and its Relationship to Migraine: Tally Largent-Milnes, PhD
June 13th 2022The assistant professor of pharmacology at the University of Arizona College of Medicine Tucson shared her insight into the endocannabinoid system and its therapeutic potential in treating migraine. [WATCH TIME: 5 minutes]
Neuronal Complexity in a Model of Migraine: Amynah Pradhan, PhD
June 12th 2022The associate professor of psychiatry at the University of Illinois at Chicago shared the findings of her and colleagues’ work that suggest that distinct cytoarchitectural changes occur in the brain that may underlie migraine chronification. [WATCH TIME: 4 minutes]
